JasonSpence

Entry for long position

做多
NASDAQ:ADAP   Adaptimmune Therapeutics plc
Strong Fundamental data has created the more recent bullish trend. I have been waiting for a safe entry point for about 2 months now after selling off some profits in the 13s. mid 10s has been my forecast for optimum entry for some time now and it looks like we are just about there. I am thinking that I will phase in throughout this week and set a stop around 9.75. Profit targets are hard to project but my gut tells me somewhere around mid 17s.
免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。